Investment analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued to investors on Monday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Shares of SRNE stock opened at $0.01 on Monday. Sorrento Therapeutics has a 52-week low of $0.00 and a 52-week high of $0.42. The firm has a fifty day moving average of $0.02 and a 200-day moving average of $0.05.
About Sorrento Therapeutics
Featured Articles
- Five stocks we like better than Sorrento Therapeutics
- What Investors Need to Know to Beat the Market
- Snap Crackles and Pops on Surprise Profit and Raised Guidance
- How to Use Stock Screeners to Find Stocks
- MarketBeat Week in Review – 4/22 – 4/26
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Stocks Leading the U.S. Agriculture Comeback
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.